A CNN report suggests the Moderna COVID-19 booster “might not be any more effective at preventing Covid-19 infections than the original shots.” Data analyzing the booster’s effectiveness revealed that “those who got the updated bivalent vaccine – the one that scientists hoped would work better – a higher percentage, 3.2%, became infected,” compared to 1.9% of those who received the original booster. Moderna did not share the initial data with the Centers for Disease Control and Prevention (CDC) vaccine advisors or with the Food and Drug Administration (FDA).
From The Blaze:
Fourteen CDC advisers reportedly convened on Sept. 1, the day after the FDA authorized Moderna's bivalent booster. Their job: to determine whether the agency should recommend that Americans get the new shot. Once again, scientists gave presentations, and once again, the infection data didn't come up. Like the scientists, Jacqueline Miller, senior vice president at Moderna, gave a presentation to the CDC advisers. As in the company president's previous presentation to the FDA vaccine advisers, Miller similarly omitted the indication that more bivalent-boosted test subjects got infected than those who had only received the original shot. Kristen Nordlund, a spokesman for the CDC, suggested the agency was aware of the data, which she downplayed, claiming the study had not been "designed to assess vaccine effectiveness."
